Dermatology patients on biologics and certain other systemic therapies should receive a “booster” messenger RNA COVID-19 vaccine dose: A critical appraisal of recent Food and Drug Administration and Advisory Committee on Immunization Practices recommendations
Reid A. Waldman, Jane M. Grant‐Kels
Topics & Concepts
MedicineAdvisory committeeFood and drug administrationImmunizationAuthorizationFamily medicineDisease controlMedical emergencyEnvironmental healthImmunologyManagementAntigenComputer scienceComputer securityEconomicsSARS-CoV-2 and COVID-19 ResearchCAR-T cell therapy researchImmunotherapy and Immune Responses